SIRT7表达预测上道尿路癌的预后不佳,接受了术后基于的辅助化疗

Yudong Cao1, Jinchao Ma1, Shuo Wang1

  • 1Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing, China.

Urologia internationalis
|February 27, 2025
PubMed
概括

高SIRT7表达预测在手术和化疗后,上道泌尿道癌 (UTUC) 患者的无疾病生存率较低. 增加的SIRT7也可能表明对免疫疗法的反应.